Lisfranc Arthritis Treatment 2026 | Podiatrist

TMT Joint	Mobility	Fusion Candidate?	Notes
1st TMT (medial cuneiform — 1st metatarsal)	Low (stable)	✅ Yes — most commonly fused	Largest joint; primary load-bearing
2nd TMT (medial cuneiform — 2nd metatarsal)	Very low (rigid)	✅ Yes — commonly fused	Lisfranc ligament attachment; key stability
3rd TMT (lateral cuneiform — 3rd metatarsal)	Low	✅ Yes — commonly fused	Part of medial column
4th TMT (cuboid — 4th metatarsal)	High (mobile)	❌ No — lateral column preserved	Fusion here causes rigid lateral column pain
5th TMT (cuboid — 5th metatarsal)	High (mobile)	❌ No — lateral column preserved	Essential for forefoot flexibility on uneven ground

Treatment	Stage	Expected Relief	Duration
Custom rigid orthotics + rocker sole	Mild–moderate	50–70% pain reduction	Long-term daily use
CAM walking boot	Moderate flare	Significant (offloads joint)	Flare-based; 2–6 weeks
Corticosteroid injection (fluoroscopy)	Moderate–severe	60–80% temporary relief	3–6 months; max 2–3/year
Carbon fiber insole plate	Mild–moderate	40–60% functional improvement	Long-term
TMT arthrodesis (fusion)	Severe / failed conservative	80–90% satisfaction rate	Permanent; 6–12 month recovery

Quick answer: Lisfranc Arthritis is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Township practices. Call (810) 206-1402.

Why Lisfranc Arthritis Develops

Lisfranc arthritis develops in the tarsometatarsal (TMT) joint complex after a Lisfranc injury — even after excellent treatment. The cartilage damage and ligament disruption that occur at the time of injury initiate a progressive arthritis process in many patients. Studies show 50–75% of Lisfranc injuries develop some degree of post-traumatic arthritis, though not all are symptomatic.

Symptoms

Chronic midfoot pain that is worse with prolonged walking, standing, or high-impact activity; arch stiffness especially in the morning; swelling over the dorsal midfoot; difficulty wearing dress shoes or walking on uneven terrain; and a measurable arch collapse compared to the uninjured side.

Timeline

Lisfranc arthritis typically becomes symptomatic 6–24 months after injury. It is a primary reason why outcomes after Lisfranc injuries continue to deteriorate over time rather than steadily improving, and why adequate initial treatment (ORIF or primary fusion) is so important.

Conservative Treatment

Custom orthotics with a stiff carbon fiber plate (to limit TMT joint motion), rocker bottom shoes, NSAIDs, corticosteroid or PRP injections into affected TMT joints, and activity modification. Many patients manage adequately with orthotics and shoe modifications for years.

Surgical Treatment: Lisfranc Fusion

Lisfranc arthrodesis (fusion of the medial three TMT joints — 1st, 2nd, and 3rd) reliably eliminates pain in the arthritic joints. The 4th and 5th TMT joints are mobile and typically not fused. Recovery involves 6–10 weeks non-weight-bearing, then progressive loading over 3–6 months to full activity.

FAQs

Is Lisfranc fusion permanent? Yes — the joints are permanently fused. However, the 4th–5th TMT joints compensate well, and most patients return to a high functional level with pain relief.

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your ankle instability, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.